On ECHEMI
Home > Drugs > Pleomorphic adenocarcinoma of lacrimal gland
Pleomorphic adenocarcinoma of lacrimal gland
Pleomorphic adenocarcinoma of the lacrimal gland, also known as malignant mixed tumor of the lacrimal gland, has clinical manifestations similar to benign pleomorphic adenoma and histologically has both benign and malignant cell characteristics.
  • Site of disease:

    Eye
  • Infectious :

    Not contagious
  • Frequent population:

    Middle-aged people
  • Related symptoms:

    Increased eye dirt eye pain visual impairment tear gland inflammation no beard, armpit and pubic hair
Related Drugs
Thymopentin injection
Indication: 1. For patients with chronic hepatitis B over 18 years old; 2. Various primary or secondary T-cell deficiency diseases (such as congenital immunodeficiency in children); 3. Certain autoimmune diseases (such as rheumatoid arthritis, systemic lupus erythematosus, etc.); 4. Various diseases with low cellular immune function (severe immunodeficiency, HIV patients, extreme immunosuppression or congenital thymic insufficiency or athymus, etc.); 5. Adjuvant treatment of tumors; 6. Patients undergoing surgical operations and severe infection operations.
Manufacturer:

Beijing SL Pharmaceutical Co., Ltd.

Thymopentin injection
Indication: 1. For patients with chronic hepatitis B over 18 years old; 2. Various primary or secondary T-cell deficiency diseases (such as congenital immunodeficiency in children); 3. Certain autoimmune diseases (such as rheumatoid arthritis, systemic lupus erythematosus, etc.); 4. Various diseases with low cellular immune function (severe immunodeficiency, HIV patients, extreme immunosuppression or congenital thymic insufficiency or athymus, etc.); 5. Adjuvant treatment of tumors; 6. Patients undergoing surgical operations and severe infection operations.
Manufacturer:

Beijing SL Pharmaceutical Co., Ltd.

Thymopentin injection
Indication: 1. For patients with chronic hepatitis B over 18 years old; 2. Various primary or secondary T-cell deficiency diseases (such as congenital immunodeficiency in children); 3. Certain autoimmune diseases (such as rheumatoid arthritis, systemic lupus erythematosus, etc.); 4. Various diseases with low cellular immune function (severe immunodeficiency, HIV patients, extreme immunosuppression or congenital thymic insufficiency or athymus, etc.); 5. Adjuvant treatment of tumors; 6. Patients undergoing surgical operations and severe infection operations.
Manufacturer:

Beijing SL Pharmaceutical Co., Ltd.

Thymopentin injection
Indication: 1. For patients with chronic hepatitis B over 18 years old; 2. Various primary or secondary T-cell deficiency diseases (such as congenital immunodeficiency in children); 3. Certain autoimmune diseases (such as rheumatoid arthritis, systemic lupus erythematosus, etc.); 4. Various diseases with low cellular immune function (severe immunodeficiency, HIV patients, extreme immunosuppression or congenital thymic insufficiency or athymus, etc.); 5. Adjuvant treatment of tumors; 6. Patients undergoing surgical operations and severe infection operations.
Manufacturer:

Beijing SL Pharmaceutical Co., Ltd.

Thymopentin injection
Indication: 1. For patients with chronic hepatitis B over 18 years old; 2. Various primary or secondary T-cell deficiency diseases (such as congenital immunodeficiency in children); 3. Certain autoimmune diseases (such as rheumatoid arthritis, systemic lupus erythematosus, etc.); 4. Various diseases with low cellular immune function (severe immunodeficiency, HIV patients, extreme immunosuppression or congenital thymic insufficiency or athymus, etc.); 5. Adjuvant treatment of tumors; 6. Patients undergoing surgical operations and severe infection operations.
Manufacturer:

Beijing SL Pharmaceutical Co., Ltd.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.